CABENUVA

CABENUVA

Cabenuva

(cabotegravir and rilpivirine)

Cabenuva is a 2-drug co-packaged product of cabotegravir, a HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).

Prescribing Information

Patient Information

Stability Tool

Medical Shorts

Ancillary Benefits of Treatment with Cabenuva

Cabenuva: Low Level Viremia and Blips

Real-World Use of Long-Acting Cabotegravir Plus Rilpivirine in Virologically Suppressed People Living With HIV

Use of Long-Acting Cabotegravir Plus Rilpivirine in Treatment-Experienced Patients Who Face Challenges With Adherence to Antiretroviral Therapy

Cabenuva Outcomes by Baseline Body Mass Index